Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation

Journal of Affective Disorders

Volumn 66, Issue 2-3, 2001, Pages 185-191

  Gyulai, Laszlo ^a   Bauer, Michael ^b,d   Garcia Espana, Felipe ^a   Hierholzer, Johannes ^c   Baumgartner, Andreas ^b   Berghöfer, Anne ^b   Whybrow, Peter C ^d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Affective Disorder; Bone density; DEXA; Dual energy X ray absorptiometry; L Thyroxine augmentation; Osteoporosis; T4

Indexed keywords

LEVOTHYROXINE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; BONE DENSITY; BONE MINERAL; BONE STRUCTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LONG TERM CARE; PATIENT SELECTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

BIPOLAR DISORDER; BONE DENSITY; DENSITOMETRY, X-RAY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; THYROXINE;

EID: 0034808251     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00306-2     Document Type: Article

References (24)

1. Bone mineral density in postmenopausal women treated with L-thyroxine
2. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study
3. Low thyrotropin levels are not associated with bone loss in older women: A prospective study
4. Treatment of refractory depression with high-dose thyroxine
5. Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders
6. Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: An open clinical trial
7. Epidemiology of osteoporosis and osteoporotic fractures
8. Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone
9. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: A meta-analysis
10. Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma
11. Long-term thyroxine treatment and bone mineral density
12. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis
13. Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis
14. Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma
15. The effect of thyroid hormone on skeletal integrity
16. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
17. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women
18. Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder
19. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women
20. Optimized interpretation and reporting of dual X-ray absorptiometry (DEXA) scans
21. Bone mineral density in women with depression
22. Consensus of an international panel on the utility of bone mass measurements in the detection of low bone mass in the adult population
23. Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy
24. The therapeutic use of triiodothyronine and high dose thyroxine in psychiatric disorder